Insider Transactions in Q3 2021 at Cue Biopharma, Inc. (CUE)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2021
|
Daniel R Passeri CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
31,677
-24.3%
|
$443,478
$14.57 P/Share
|
|
Sep 30
2021
|
Daniel R Passeri CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
75,000
+36.52%
|
-
|
|
Sep 24
2021
|
Daniel R Passeri CHIEF EXECUTIVE OFFICER |
BUY
Open market or private purchase
|
Direct |
3,400
+5.78%
|
$47,600
$14.72 P/Share
|
|
Sep 23
2021
|
Anish Suri PRESIDENT AND CSO |
SELL
Open market or private sale
|
Direct |
20,000
-21.09%
|
$300,000
$15.23 P/Share
|
|
Sep 23
2021
|
Anish Suri PRESIDENT AND CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+17.42%
|
$120,000
$6.42 P/Share
|
|
Aug 23
2021
|
Kerri Ann Millar CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,961
-15.77%
|
-
|
|
Aug 23
2021
|
Kerri Ann Millar CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,667
+34.91%
|
-
|